Skip to main content


Viral Hepatitis Elimination

In the past, viral hepatitis was a hidden epidemic with little hope for a treatment or cure. Today, that is no longer the case and 2016 was the turning point. We are in the first year of the first-ever Global health sector strategy on viral hepatitis. This, in addition to the advent of highly-effective all-oral direct acting antivirals to cure hepatitis C, means there is an unprecedented global level of attention being given to viral hepatitis. The series focuses on research and review submissions as well as patient and civil society perspectives on hepatitis elimination.

In this cross-journal series, Hepatology, Medicine and Policy, BMC Medicine, BMC Infectious Disease, and BMC Public Health examine how far efforts towards viral hepatitis elimination have come and what remains to be done. This rolling series includes research from around the world. Selected research articles will be included on viral hepatitis elimination strategy, health systems and policy, intervention, implementation research, economics, epidemiology, ethics sand human rights, social mediators of health outcomes, basic and clinical science, health services, and more. Invited reviews, roundtables and commentaries will also be part of the series.

For pre-submission enquiries, please contact the journal you wish to submit to.

  1. Content type: Research article

    The major infectious diseases of hepatitis B has constituted an acute public health challenge in China. An effective and affordable HBV control model is urgently needed. A national project of Community-based C...

    Authors: Bing Ruan, Zhixin Yu, Shigui Yang, Kaijin Xu, Jingjing Ren, Jun Yao, Nanping Wu, Chengbo Yu, Min Deng, Tiansheng Xie, Ping Chen, Chencheng Wang, Yiping Li, Yanhong Zhao, Jifang Sheng, Yunde Hou…

    Citation: BMC Infectious Diseases 2019 19:617

    Published on:

  2. Content type: Research article

    Hepatitis B virus (HBV) is a hepatotropic deoxyribonucleic acid (DNA) virus which causes death. More than 300 million people have chronic liver infections globally and about 600,000 people die annually from ac...

    Authors: Abayneh Tunje Tanga, Misanew Andargie Teshome, Desta Hiko, Chaltu Fikru and Gemechu Kejela Jilo

    Citation: BMC Infectious Diseases 2019 19:602

    Published on:

  3. Content type: Research article

    Intestinal parasitic infections are still common in low-income countries including Ethiopia, particularly in children due to low-quality drinking water, poor personal and environmental sanitation. Disabled ind...

    Authors: Agumas Ayalew Fentahun, Anemaw Asrat, Abebayehu Bitew and Selamawit Mulat

    Citation: BMC Infectious Diseases 2019 19:549

    Published on:

  4. Content type: Research article

    Due to no clinical symptoms in the compensated stage of cirrhosis, it is usually diagnosed when decompensated complications occur. In this study, the noninvasive circulating biomarkers for early detection to c...

    Authors: Liangshan Hu, Yan Zhu, Jingqian Zhang, Wei Chen, Zeyong Li, Lihua Li, Liping Zhang and Donglin Cao

    Citation: BMC Infectious Diseases 2019 19:523

    Published on:

  5. Content type: Research article

    There have been a number of studies about seroprevalence of HEV among pregnant women in Africa. However, the finding of seroprevalence of HEV infection among pregnant women is variable and inconsistent. Theref...

    Authors: Mulat Dagnew, Amare Belachew, Moges Tiruneh and Feleke Moges

    Citation: BMC Infectious Diseases 2019 19:519

    Published on:

  6. Content type: Research article

    The relationship between chronic hepatitis B virus (HBV) infection with gestational diabetes mellitus (GDM) remains unclear. This study aimed to identify the association between maternal HBsAg-positive status ...

    Authors: Songxu Peng, Zhihua Wan, Xiaofang Lin, Xiu Li and Yukai Du

    Citation: BMC Infectious Diseases 2019 19:147

    Published on:

  7. Content type: Research article

    Hepatitis C virus (HCV) is one of the main causes of chronic liver disease worldwide. Prevalence of HCV in homeless populations ranges from 3.9 to 36.2%. The HepCheck study sought to investigate and establish ...

    Authors: John S. Lambert, Ross Murtagh, Dee Menezes, Austin O’Carroll, Carol Murphy, Walter Cullen, Tina McHugh, Gordana Avramovic, Willard Tinago and Marie Claire Van Hout

    Citation: BMC Infectious Diseases 2019 19:128

    Published on:

  8. Content type: Review

    The Netherlands is striving to achieve national elimination of the hepatitis C virus (HCV) as one of the first countries worldwide. The favorable HCV epidemiology with both low prevalence and incidence, togeth...

    Authors: P. A. M. Kracht, J. E. Arends, K. J. van Erpecum, A. Urbanus, J. A. Willemse, A. I. M. Hoepelman and E. A. Croes

    Citation: Hepatology, Medicine and Policy 2018 3:12

    Published on:

  9. Content type: Research

    Universal access to the hepatitis C direct acting antiviral (DAAs) regimens presents a unique opportunity to eliminate hepatitis C in Australia. Large numbers of Australians have already been cured using these...

    Authors: Jacqueline A. Richmond, Jeanne Ellard, Jack Wallace, Rachel Thorpe, Peter Higgs, Margaret Hellard and Alexander Thompson

    Citation: Hepatology, Medicine and Policy 2018 3:8

    Published on:

  10. Content type: Research

    Many persons infected with Hepatitis B virus (HBV) and Hepatitis C virus (HCV) in the past are now lost to follow-up. The aim of the Northern Holland Hepatitis Retrieval Project (NHHRP) is to retrieve and re-e...

    Authors: N. Beekmans and M. Klemt-Kropp

    Citation: Hepatology, Medicine and Policy 2018 3:5

    Published on:

  11. Content type: Minireview

    Chronic hepatitis B virus (HBV) infection is a global public health issue. Although the disease cannot be cured effectively, disease management has been improved over the past decade. The introduction of poten...

    Authors: Tai-Chung Tseng and Jia-Horng Kao

    Citation: BMC Medicine 2017 15:53

    Published on: